AstraZeneca Announces Q4 Financial Results, Coronavirus Fears Weigh on GuidanceThe Motley Fool • 02/15/20
AstraZeneca's (AZN) CEO Pascal Soriot on Q4 2019 Results - Earnings Call TranscriptSeeking Alpha • 02/14/20
5 Big Dividend Pharmaceutical Stocks to Buy as Health Care Could Explode Higher24/7 Wall Street • 02/11/20
LogicBio Therapeutics Provides Update on FDA Review of Investigational New Drug Application for LB-001 for Methylmalonic AcidemiaGlobeNewsWire • 02/10/20
Analysis: Major Pharmaceuticals' January Drug Price Hikes Were Smallest in at Least 6 YearsThe Motley Fool • 02/05/20
AstraZeneca and Merck Get an FDA Priority Review for Lynparza in Prostate CancerThe Motley Fool • 01/21/20